Clinical Trials
5 trialsNCT05022797 2024-05-13
Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Terminated
NCT04668768 2024-03-22
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
Fox Chase Cancer Center
Phase 2 Suspended
NCT02022358 2015-06-04
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
University College, London
Phase 2 Terminated
NCT00634322 2014-09-15
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
BTG International Inc.
Phase 2 Terminated
NCT00219791 2014-09-11
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
BTG International Inc.
Phase 2 Completed